Inventor
WILDE RICHARD G
US20 patents
⚠️ This page may combine multiple inventors who share the name “WILDE RICHARD G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DU PONT MERCK PHARMA
7 patentsUS5491152AFeb 13, 1996
Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
DU PONT MERCK PHARMA40 citations92
US5364875ANov 15, 1994
Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
DU PONT MERCK PHARMA50 citations92
US5358946AOct 25, 1994
Heterocycle-substituted amides, carbamates and ureas as agents for the treatment of atherosclerosis
DU PONT MERCK PHARMA28 citations92
US5583147ADec 10, 1996
Amides for the treatment of atherosclerosis
DU PONT MERCK PHARMA49 citations91
US5310748AMay 10, 1994
Imidazoles for the treatment of atherosclerosis
DU PONT MERCK PHARMA45 citations91
US5290801AMar 1, 1994
Benzimidazoles for the treatment of atherosclerosis
DU PONT MERCK PHARMA56 citations89
US5478830ADec 26, 1995
Fused-ring heterocycles for the treatment of atherosclerosis
DU PONT MERCK PHARMA9 citations73
PTC THERAPEUTICS INC
5 patentsUS7405233B2Jul 29, 2008
Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
PTC THERAPEUTICS INC27 citations92
US7902241B2Mar 8, 2011
Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
PTC THERAPEUTICS INC2 citations62
US7449570B2Nov 11, 2008
Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
PTC THERAPEUTICS INC2 citations61
US7291603B2Nov 6, 2007
Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
PTC THERAPEUTICS INC3 citations58
US7763656B2Jul 27, 2010
Use of Acetylamino benzoic acid compounds for nonsense suppression and the treatment of disease
PTC THERAPEUTICS INC0 citations50
BRISTOL MYERS SQUIBB PHARMA CO
4 patentsUS6589952B2Jul 8, 2003
Imidazo[1,2-a]pyrazines for the treatment of neurological disorders
BRISTOL MYERS SQUIBB PHARMA CO30 citations92
US6958341B2Oct 25, 2005
Pyrazolopyrimidines as CRF antagonists
BRISTOL MYERS SQUIBB PHARMA CO8 citations73
US7045529B2May 16, 2006
Imidazopyrimidinyl and imidazopyri dinyl derivatives
BRISTOL MYERS SQUIBB PHARMA CO4 citations60
US7026317B2Apr 11, 2006
Pyrazolotriazines as CRF antagonists
BRISTOL MYERS SQUIBB PHARMA CO0 citations52